Vytalize Health

Overview
Activities
News
Preventive Healthcare?
Hospital-at-Home?
Product stageSegments
Go-to-Market
?
Population Health Management Solutions
?

Vytalize Health focuses on offering value-based care through partnerships with independent primary care practices. The company first launched in 2014 as a primary care practice in New York focused on Medicare members. It later developed a tech-driven solution consisting of a risk-bearing entity, a technology platform. It claims to offer a unique practice-engagement model to help its clients spend more time with high-risk populations.

The company offers an "all-in-one" solution that integrates virtual and in-home care services, chronic disease management, remote monitoring, and data analytics. Vytalize Health's platform analyzes clinical notes, claims data, social determinants of health, and hospital feeds to identify care gaps and actionable insights.

It acquired the AI-driven, last-mile patient engagement platform MedPilot in 2021. Furthermore, in April 2023, Vytalize Health acquired the majority interest in Independent Physician Association (IPA) of New York to accelerate its expansion into Medicare Advantage, commercial plans, Medicaid, and multi-specialty care.

Key customers and partnerships

Vytalize Health partners with both small and large primary care practices to support their transition to value-based care by providing data about their patient, practice, finance, and enrollment. As of May 2024, the company had partnered with over 5,000 providers across 36 states, offering services to more than 260,000 patients.

Funding and Financials

In February 2023, the firm raised USD 100 million in a funding round led by Monroe Capital and Enhanced Healthcare Partners. The funds were allocated towards hiring additional staff, improving its technology, and strengthening primary care practices to support value-based care for seniors.

HQ location:
Hoboken NJ USA
Founded year:
2014
Employees:
251-500
IPO status:
Private
Total funding:
USD 175.5 mn
Last Funding:
USD 100.0 mn (Series C; Feb 2023)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.